01
TARGET NEURODEGENERATIVE DISEASE AT ITS SOURCE
© 2024 Nuravax
Eliminate Neurodegenerative Proteins to Preserve Cognitive Health

Nuravax immunotherapies prevent, cure, and delay untreatable neurological disease
PIONEERING IMMUNOTHERAPY
APPROACH
Formulate Vaccine Therapies to Eradicate Neurodegenerative Disease

Nuravax is committed to preventing and curing central nervous system (CNS) disorders through the patient’s own immune system. We design highly specific vaccine therapies using our proprietary MultiTEP platform to target the root causes of neurological disease. Nuravax is currently developing vaccines to combat Alzheimer’s and Parkinson’s diseases.
02
Preserve Neurological Health Through Strategic Vaccine Development

Every Nuravax immunotherapy starts with our unique MultiTEP vaccine platform. MultiTEP is designed to overcome common immunotherapy hurdles, ensuring a robust immune response with every vaccine.
03
PIPELINE
PIPELINE
PUBLICATIONS
Discover Our Research Excellence

Nuravax researchers are leading contributors to the scientific community. Our experts have published numerous comprehensive research studies, demonstrating our deep commitment to advancing the science and treatment of neurological disease.
04
NEWS
NEWS
05
Learn How Nuravax Is Making Waves
CONTACT
info@nuravax.com
06
5270 California Ave., Suite 300
Irvine, CA 92617
+16573659397